Keyphrases
Acute Ischemic Stroke
33%
Acute Large Vessel Occlusion Stroke
33%
Acute Stroke
37%
Advanced Malignancies
6%
Alberta Stroke Programme Early CT Score (ASPECTS)
9%
Alteplase
14%
Arterial Occlusion
8%
Between-group
9%
Cerebral Ischemia
22%
Clinical Outcomes
8%
Clot
37%
Comparative Analysis
33%
Complication Rate
13%
Defect Area
13%
Distal Occlusion
66%
Double-blind Randomized Controlled Trial
33%
Endovascular Thrombectomy
14%
First-pass Reperfusion
8%
Functional Outcome
9%
Intravenous Thrombolysis
33%
Ischemia-reperfusion Injury
9%
Large Vessel Occlusion
8%
Mechanical Thrombectomy
33%
Microvascular Free Flap Reconstruction
13%
Mini
33%
Modified Rankin Scale
17%
Nerinetide
33%
New Primary
6%
NIH Stroke Scale
8%
Number of Passes
7%
Occlusion
8%
Patient Demographics
13%
Pinning Techniques
33%
Placebo
19%
Radial Forearm Free Flap
33%
Reperfusion
31%
Retriever
44%
Retrospective Review
14%
Scalp
20%
Scalp Defect
33%
Scapula
6%
Single Center
7%
Site Selection
6%
Surgical Excision
6%
Thrombectomy
70%
Thromboaspiration
12%
Thrombolysis
22%
Thrombolysis in Cerebral Infarction
20%
Trevo
40%
Underutilization
6%
Medicine and Dentistry
5 Nitro 2 (3 Phenylpropylamino)benzoic Acid
16%
Adjuvant Therapy
8%
Adverse Event
8%
Alteplase
33%
Angiography
8%
Anterior Cerebral Artery
8%
Apoplexy
100%
Artery Occlusion
16%
Artery Spasm
8%
Blood Clot Lysis
83%
Brain Infarction
50%
Brain Ischemia
46%
Computed Tomography Angiography
8%
Disks Large Homolog 4
8%
Division
33%
Emergency Care
8%
Free Tissue Graft
33%
Hematoma
8%
Intention-to-Treat Analysis
8%
Ischemia
16%
Large Vessel Occlusion
41%
Mechanical Thrombectomy
33%
Middle Cerebral Artery
16%
Middle Cerebral Artery Occlusion
25%
Modified Rankin Scale
27%
National Institutes of Health Stroke Scale
25%
Percutaneous Thrombectomy
25%
Placebo
33%
Placebo-Controlled Study
8%
Posterior Cerebral Artery
8%
Randomized Controlled Trial
33%
Scalp
33%
Single Drug Dose
8%
Subarachnoid Hemorrhage
8%
Thrombectomy
68%
Thrombus
16%
Thrombus Aspiration
25%
Treatment Effect
16%
